Diala El-Maouche

Diala El-Maouche

Auto-generated profile, based on publicly available information

Diala El-Maouche

National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in The Lancet
Verified
Journal Article
Closed access
DEDiala El-Maouche
Diala El-Maouche
WAWiebke Arlt
Wiebke Arlt
DMDeborah P Merke
Deborah P Merke

1 October 2016 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
DEDiala El-Maouche
Diala El-Maouche
SSSamira M. Sadowski
Samira M. Sadowski
GPGeorgios Z. Papadakis
Georgios Z. Papadakis
LGLori Guthrie
Lori Guthrie
CCCandice Cottle-Delisle
Candice Cottle-Delisle
MCMichael T. Collins
Michael T. Collins
Context: Phosphaturic mesenchymal tumors (PMTs) are small, typically difficult to localize, and express somatostatin receptors. Recent work suggests imaging studies using 68Gallium (68Ga)-conjugated somatostatin peptide analogues, such as 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)TATE, which enables somatostatin receptor imaging with positron emission tomography (PET), may be useful at identifying these tumors. Objective: Our objective was to evaluate the use of 68Ga-DOTATATE PET/computed tomography (CT) for tumor localization in tumor-induced osteomalacia (TIO). Design: This was a single-center prospective study of patients with TIO. Setting: The study was conducted at the National Institutes of Health Clinical Center between February 2014 and February 2015. Subjects: Eleven subjects (six females, five males) with TIO were included. Intervention: Subjects underwent 68Ga-DOTATATE PET/CT in addition to 111In-pentetreotide single-photon emission CT (Octreoscan- SPECT/CT) and fluorodeoxyglucose-PET/CT (18F FDG-PET/CT) scan. Main Outcome Measures: Localization of PMTs on the previously described imaging modalities were determined. Results: The tumor was successfully localized in 6/11 (54.5%) subjects (one was metastatic). The tumor was identified by 68Ga-DOTATATE in all six cases. Both Octreoscan-SPECT/CT and 18F FDG-PET each identified the tumor in 4/6. In no cases was 68Ga-DOTATATE the only imaging study to identify the tumor. Conclusions: In this first prospective study comparing 68Ga-DOTATATE PET/CT to Octreoscan-SPECT/CT and 18F FDG-PET in TIO localization, 68Ga-DOTATATE PET/CT demonstrated the greatest sensitivity and specificity, suggesting that it may be the best single study for localization of PMTs in TIO.

29 January 2013 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
WCWilliam H Chong
William H Chong
PAPanagiota Andreopoulou
Panagiota Andreopoulou
CCClara C Chen
Clara C Chen
JRJames Reynolds
James Reynolds
LGLori Guthrie
Lori Guthrie
MCMichael T Collins
Michael T Collins
Tumor‐induced osteomalacia (TIO) is a rare disorder of phosphate wasting due to fibroblast growth factor‐23 (FGF23)‐secreting tumors that are often difficult to locate. We present a systematic approach to tumor localization and postoperative biochemical changes in 31 subjects with TIO. All had failed either initial localization, or relocalization (in case of recurrence or metastases) at outside institutions. Functional imaging with 111Indium‐octreotide with single photon emission computed tomography (octreo‐SPECT or SPECT/CT), and 18fluorodeoxyglucose positron emission tomography/CT (FDG‐PET/CT) were performed, followed by anatomic imaging (CT, MRI). Selective venous sampling (VS) was performed when multiple suspicious lesions were identified or high surgical risk was a concern. Tumors were localized in 20 of 31 subjects (64.5%). Nineteen of 20 subjects underwent octreo‐SPECT imaging, and 16 of 20 FDG‐PET/CT imaging. Eighteen of 19 (95%) were positive on octreo‐SPECT, and 14 of 16 (88%) on FDG‐PET/CT. Twelve of 20 subjects underwent VS; 10 of 12 (83%) were positive. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were as follows: sensitivity = 0.95, specificity = 0.64, PPV = 0.82, and NPV = 0.88 for octreo‐SPECT; sensitivity = 0.88, specificity = 0.36, PPV = 0.62, and NPV = 0.50 for FDG‐PET/CT. Fifteen subjects had their tumor resected at our institution, and were disease‐free at last follow‐up. Serum phosphorus returned to normal in all subjects within 1 to 5 days. In 10 subjects who were followed for at least 7 days postoperatively, intact FGF23 (iFGF23) decreased to near undetectable within hours and returned to the normal range within 5 days. C‐terminal FGF23 (cFGF23) decreased immediately but remained elevated, yielding a markedly elevated cFGF23/iFGF23 ratio. Serum 1,25‐dihydroxyvitamin D3 (1,25D) rose and exceeded the normal range. In this systematic approach to tumor localization in TIO, octreo‐SPECT was more sensitive and specific, but in many cases FDG‐PET/CT was complementary. VS can discriminate between multiple suspicious lesions and increase certainty prior to surgery. Sustained elevations in cFGF23 and 1,25D were observed, suggesting novel regulation of FGF23 processing and 1,25D generation.

1 February 2014 in Thyroid®
Verified
Journal Article
Closed access
MEMyrto Eliades
Myrto Eliades
DEDiala El-Maouche
Diala El-Maouche
CCChitra Choudhary
Chitra Choudhary
BZBruce Zinsmeister
Bruce Zinsmeister
KBKenneth D. Burman
Kenneth D. Burman
Background: Takotsubo or stress-induced cardiomyopathy is a form of reversible cardiomyopathy commonly associated with emotional or physical stress. Thyrotoxicosis has been identified as a rare cause of Takotsubo cardiomyopathy, with only 12 cases reported in the literature. Here, we report a case of thyroid storm presenting with Takotsubo cardiomyopathy in the setting of Graves' disease. Patient Findings: A 71-year-old woman presented with abdominal pain, vomiting, confusion, and history of weight loss. She was initially diagnosed and treated for diabetic ketoacidosis at another hospital and was transferred to our hospital one day after initial presentation because of concern for acute coronary syndrome. A diagnosis of Takotsubo cardiomyopathy was made on the basis of cardiac catheterization. At that time, she was diagnosed and treated for thyroid storm. Follow-up 7 weeks later revealed improvement of her cardiac function and near-normalization of thyroid hormone levels. Summary: In this patient, who presented with symptoms of heart failure, acute coronary syndrome was initially considered, but the diagnosis of Takotsubo cardiomyopathy associated with thyroid storm was ultimately made based on cardiac catheterization and laboratory investigation. Conclusions: Thyrotoxicosis is associated with adverse disturbances in the cardiovascular system. Takotsubo cardiomyopathy could be a presenting manifestation of thyroid storm, perhaps related to excess catecholamine levels or sensitivity.

22 March 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
DEDiala El-Maouche
Diala El-Maouche
CHCourtney J Hargreaves
Courtney J Hargreaves
NSNinet Sinaii
Ninet Sinaii
AMAshwini Mallappa
Ashwini Mallappa
PVPadmasree Veeraraghavan
Padmasree Veeraraghavan
DMDeborah P Merke
Deborah P Merke
Context Congenital adrenal hyperplasia (CAH) patients are at risk for life-threatening adrenal crises. Management of illness episodes aims to prevent adrenal crises. Objective We evaluated rates of illnesses and associated factors in a cohort of CAH patients followed prospectively and receiving repeated glucocorticoid stress dosing education. Methods Longitudinal analysis of 156 CAH patients followed at the National Institutes of Health Clinical Center over 23 years was performed. The rates of illnesses and stress dose days, emergency room visits, hospitalizations, and adrenal crises were analyzed in relation to phenotype, age, sex, treatment, and hormonal evaluations. Results A total of 2298 visits were evaluated. Patients were followed for 9.3 ± 6.0 years. During childhood there were more illness episodes and stress dosing than adulthood (P<0.001), however, more ER visits and hospitalizations occurred during adulthood (P≤0.03). The most robust predictors of stress dosing were young age, low hydrocortisone dose, and high fludrocortisone dose during childhood, and female sex during adulthood. Gastrointestinal and upper respiratory tract infections were the two most common precipitating events for adrenal crises and hospitalizations across all ages. Adrenal crisis with probable hypoglycemia occurred in 11 pediatric patients (ages 1.1 -11.3 years). Undetectable epinephrine was associated with ER visits during childhood (P=0.03) and illness episodes during adulthood (P=0.03). Conclusions Repeated stress-related glucocorticoid dosing teaching is essential, but revised age-appropriate guidelines for the management of infectious illnesses are needed for patients with adrenal insufficiency that aim to reduce adrenal crises and prevent hypoglycemia, particularly in children.

29 February 2016 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
DED. El-Maouche
D. El-Maouche
CDC. E. Dumitrescu
C. E. Dumitrescu
PAP. Andreopoulou
P. Andreopoulou
RGR. I. Gafni
R. I. Gafni
BBB. A. Brillante
B. A. Brillante
MCM. T. Collins
M. T. Collins